Adrenocortical carcinoma (ACC) is a heterogenous group of diseases with different clinical
behaviour between adult and paediatric patients. In addition, three histological variants …

The inferior vena cava (IVC) is the largest vein in the body, draining blood from the
abdomen, pelvis and lower extremities. This pictorial review summarises normal anatomy …

Genetic mutations accumulate in an organism's body throughout its lifetime. While somatic
single-nucleotide variants have been well characterized in the human body, the patterns …

Mitotane is the only adrenolytic drug approved by the Food and Drug Administration for
treating adrenocortical carcinoma (ACC). This drug has cytotoxic effects on tumour tissues; it …

Objective: The aim of this Disease State Clinical Review is to provide a practical approach to
patients with newly diagnosed adrenocortical carcinoma, as well as to follow-up and …

Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy with an annual incidence
of~ 1 case per million population. Differentiating between ACC and benign adrenocortical …

Simple Summary Adrenocortical cancer is a very rare form of endocrine cancer with dismal
prognosis. Preclinical models such as cell lines, organoids, and mouse models are essential …

Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis. The current
treatment standards include complete surgical resection for localized resectable disease …

Adrenocortical carcinoma (ACC) is a rare tumor with a poor prognosis. Most tumors are
either metastatic or locally invasive at the time of diagnosis. Differentiation between ACC …

Background Primary malignancies of the adrenal glands are rare. Epidemiologic
assessment of primary adrenal malignancies is lacking and has been limited to case reports …